Emblem Corp. produces, distributes, and sells medical cannabis and cannabis derivatives in Canada. The company also operates medical cannabis education centers to provide education services for making informed decisions about medical cannabis treatment options to physicians and patients. In addition, it provides various accessories. Emblem Corp. has a strategic partnership with GreenSpace Brands to develop and commercialize cannabidiol infused health and beauty products. The company is headquartered in Toronto, Canada. As of March 14, 2019, Emblem Corp. operates as a subsidiary of Aleafia Health Inc.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone(416) 962-3300
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees74
Next Earnings DateN/A
OptionableNot Optionable
Emblem (OTCMKTS:EMMBF) Frequently Asked Questions
What is Emblem's stock symbol?
Emblem trades on the OTCMKTS under the ticker symbol "EMMBF."
Has Emblem been receiving favorable news coverage?
News headlines about EMMBF stock have been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Emblem earned a daily sentiment score of 1.7 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Emblem.
Who are some of Emblem's key competitors?
Some companies that are related to Emblem include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Almirall (LBTSF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Biocure Technology (CURE), Canada House Wellness Group (CHV), Cannabics Pharmaceuticals (CNBX), CannaRoyalty (ORHOF), Cardiome Pharma (COM), China Longyi Group Int'l (CGYG), Creative Medical Technology (CELZ) and Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (CYCCP).
What other stocks do shareholders of Emblem own?
Who are Emblem's key executives?
Emblem's management team includes the folowing people:
- Mr. Nicholas Dean, CEO, Pres & Director
- Mr. Harvey Allan Shapiro, VP (Age 74)
- Mr. Maxim Zavet, VP (Age 39)
- Mr. Gordon Howard Fox, Advisor
- Mr. Alexander Stojanovic, Chief Financial Officer
How do I buy shares of Emblem?
Shares of EMMBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Emblem's stock price today?
One share of EMMBF stock can currently be purchased for approximately $1.40.
What is Emblem's official website?
How can I contact Emblem?
The company can be reached via phone at (416) 962-3300.
MarketBeat Community Rating for Emblem (OTCMKTS EMMBF)
MarketBeat's community ratings are surveys of what our community members think about Emblem and other stocks. Vote "Outperform" if you believe EMMBF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMMBF will underperform the S&P 500 over the long term. You may vote once every thirty days.
